GSK
About: In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Employees: 70,200
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
93% more call options, than puts
Call options by funds: $200M | Put options by funds: $104M
13% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 78
1% more funds holding
Funds holding: 871 [Q2] → 881 (+10) [Q3]
2% more capital invested
Capital invested by funds: $12.4B [Q2] → $12.6B (+$290M) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 10 [Q2] → 10 (+0) [Q3]
0.3% less ownership
Funds ownership: 7.77% [Q2] → 7.47% (-0.3%) [Q3]
4% less repeat investments, than reductions
Existing positions increased: 302 | Existing positions reduced: 316
Research analyst outlook
We haven’t received any recent analyst ratings for GSK.
Financial journalist opinion
Based on 21 articles about GSK published over the past 30 days